Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2021 - 05 - 28 save search
Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer
Published: 2021-05-28 (Crawled : 21:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.82%
H: 2.28%
C: -0.95%
fda lung cancer fda approval cancer approval diagnostic
Grupo Aeroportuario Del Pacifico Pays Capital Stock Reduction Approved at the General Extraordinary Shareholders’ Meeting
Published: 2021-05-28 (Crawled : 21:00) - globenewswire.com
PAC | $176.15 -1.29% 0.0% 63K
|
Transportation
| Email alert
Add to watchlist
approval
BridgeBio Pharma’s Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma
Published: 2021-05-28 (Crawled : 19:00) - globenewswire.com
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
| Email alert
Add to watchlist
fda fda approval approval pharma
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-28 (Crawled : 18:31) - fda.gov
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
| Email alert
Add to watchlist
AGIO | $31.67 -0.44% -0.44% 540K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
Published: 2021-05-28 (Crawled : 17:00) - prnewswire.com
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.82%
H: 2.28%
C: -0.95%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.73%
fda lung cancer therapy cancer drug fda approval approval
FDA Panel Gives Narrow Nod of Approval to Provention's Diabetes Drug
Published: 2021-05-28 (Crawled : 16:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: -14.79%
H: 4.4%
C: -16.37%
diabetes fda drug approval
Northern Star Acquisition Corp. Stockholders Approve Proposed Merger With BARK
Published: 2021-05-28 (Crawled : 15:00) - prnewswire.com
SNAP | News S | $11.08 -2.72% -4.25% 31M
|
Technology Services
|
| O: 0.01%
H: 2.58%
C: 1.71%
BOX 4 | $27.28 -0.07% -0.07% 1.1M
|
Technology Services
|
| O: 0.09%
H: 3.1%
C: 1.83%
acquisition acquisition corp merge approval
Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval
Published: 2021-05-28 (Crawled : 15:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.01%
H: 0.93%
C: 0.11%
diabetes treatment approval
Atlas Corp. Announces Approval for Listing on the Nasdaq Global Market of its 7.125% Senior Unsecured Notes due 2027
Published: 2021-05-28 (Crawled : 13:00) - prnewswire.com
ATCO | $15.48 0.0% 0
|
Finance
|
| O: -0.15%
H: 2.58%
C: 2.21%
approval
Nasdaq Approves High Tide's Application to List
Published: 2021-05-28 (Crawled : 11:00) - prnewswire.com
ACB | $7.2 14.65% 12.78% 5.7M
|
Process Industries
|
| O: 0.67%
H: 6.98%
C: 6.98%
approval application nasdaq
FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D)
Published: 2021-05-28 (Crawled : 02:00) - prnewswire.com
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: -14.79%
H: 4.4%
C: -16.37%
diabetes fda risk approval teplizumab
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.